Search results

Filter

Document Type

Status

Date

Guidance category

Advice category

81 results for kidney cancer

Relevance Date

  1. Renal cancer

    Everything NICE has said on renal (kidney) cancer in an interactive flowchart

    NICE Pathway
    Last updated

  5. Kidney conditions

    Everything NICE has said on kidney (renal) conditions in an interactive flowchart

    NICE Pathway
    Last updated

  6. Acute kidney injury (QS76)

    This quality standard covers preventing, detecting and managing acute kidney injury in adults, young people and children. Acute kidney injury is sudden damage to the kidneys, which can sometimes result in kidney failure. The quality standard includes assessment by non-specialists and when to refer to specialist services. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    View quality statements

  8. Pemetrexed for the first-line treatment of non-small-cell lung cancer (TA181)

    Evidence-based recommendations on pemetrexed disodium (Alimta) for the first-line treatment of non-small-cell lung cancer (NSCLC)

    Technology appraisal guidance
    Published
    View recommendations

  9. Nivolumab for previously treated squamous non-small-cell lung cancer (TA483)

    Evidence-based recommendations on nivolumab (Opdivo) for locally advanced or metastatic squamous non-small-cell lung cancer (NSCLC) in adults after chemotherapy

    Technology appraisal guidance
    Published
    View recommendations

  10. Nivolumab for previously treated non-squamous non-small-cell lung cancer (TA484)

    Evidence-based recommendations on nivolumab (Opdivo) for locally advanced or metastatic (secondary) non-squamous non-small-cell lung cancer in adults after

    Technology appraisal guidance
    Published
    View recommendations

  11. Neutropenic sepsis: prevention and management in people with cancer (CG151)

    This guideline covers preventing, identifying and managing neutropenic sepsis in children, young people and adults receiving treatment for cancer in the community and in secondary and tertiary care. It aims to reduce the risk of infection in people with neutropenia (low number of white blood cells) who are receiving anticancer treatment and improve management of neutropenic sepsis.

    Clinical guideline
    Published
    View recommendations

  12. Topotecan for the treatment of recurrent and stage IVB cervical cancer (TA183)

    Evidence-based recommendations on topotecan (Hycamtin) for treating recurrent stage IVB (stage 4B) cervical cancer (cancer of the cervix)

    Technology appraisal guidance
    Published
    View recommendations

  13. Palliative care for adults: strong opioids for pain relief (CG140)

    This guideline covers safe and effective prescribing of strong opioids for pain relief in adults with advanced and progressive disease. It aims to clarify the clinical pathway for prescribing and help to improve pain management and patient safety. Care during the last 2 to 3 days of life is covered by care of dying adults in the last days of life .

    Clinical guideline
    Last updated
    View recommendations

  14. Urogenital conditions

    Everything NICE has said on urogenital conditions in an interactive flowchart

    NICE Pathway
    Last updated